NASDAQ:LMNXLuminex Stock Price, Forecast & News

Luminex's stock was trading at $27.11 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, LMNX stock has increased by 21.1% and is now trading at $32.84. View which stocks have been most impacted by Coronavirus.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Luminex in the last year. There are currently 1 sell rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Luminex.

Luminex is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Luminex.

Luminex Co. (NASDAQ:LMNX) released its earnings results on Monday, May, 4th. The medical instruments supplier reported $0.01 earnings per share for the quarter, beating the consensus estimate of ($0.01) by $0.02. The medical instruments supplier earned $90.40 million during the quarter, compared to analyst estimates of $82.30 million. Luminex had a negative return on equity of 1.25% and a negative net margin of 1.81%. The company's revenue for the quarter was up 9.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.07 EPS. View Luminex's earnings history.

Luminex declared a quarterly dividend on Tuesday, May 26th. Shareholders of record on Thursday, June 18th will be given a dividend of $0.09 per share on Thursday, July 9th. This represents a $0.36 annualized dividend and a dividend yield of 1.10%. The ex-dividend date of this dividend is Wednesday, June 17th. View Luminex's dividend history.

Luminex issued an update on its FY 2020 After-Hours earnings guidance on Monday, May, 4th. The company provided EPS guidance of for the period. The company issued revenue guidance of $362 million, compared to the consensus revenue estimate of $350.06 million.

2 brokers have issued 1-year target prices for Luminex's shares. Their forecasts range from $21.00 to $32.00. On average, they anticipate Luminex's share price to reach $26.50 in the next twelve months. This suggests that the stock has a possible downside of 19.3%. View analysts' price targets for Luminex.

Media headlines about LMNX stock have been trending somewhat negative recently, InfoTrie reports. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Luminex earned a news sentiment score of -1.3 on InfoTrie's scale. They also assigned media headlines about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news about Luminex.

Luminex saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 4,000,000 shares, an increase of 23.8% from the May 31st total of 3,230,000 shares. Based on an average trading volume of 773,300 shares, the days-to-cover ratio is presently 5.2 days. Approximately 9.5% of the shares of the stock are short sold. View Luminex's Current Options Chain.

Some companies that are related to Luminex include Thermo Fisher Scientific (TMO), Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), Waters (WAT), PerkinElmer (PKI), BIO-TECHNE (TECH), Charles River Laboratories Intl. (CRL), Bruker (BRKR), Pacific Biosciences of California (PACB), Fluidigm (FLDM), Harvard Bioscience (HBIO), aTyr Pharma (LIFE) and BG Medicine (BGMD). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Luminex investors own include Baidu (BIDU), NVIDIA (NVDA), Crispr Therapeutics (CRSP), Cisco Systems (CSCO), Inovio Pharmaceuticals (INO), Square (SQ), Verizon Communications (VZ), AbbVie (ABBV), American Express (AXP) and Micron Technology (MU).

Luminex trades on the NASDAQ under the ticker symbol "LMNX."

Shares of LMNX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of LMNX stock can currently be purchased for approximately $32.84.

Luminex has a market capitalization of $1.50 billion and generates $334.64 million in revenue each year. The medical instruments supplier earns $-3,840,000.00 in net income (profit) each year or ($0.21) on an earnings per share basis. Luminex employs 1,247 workers across the globe.

The official website for Luminex is www.luminexcorp.com.

Luminex's mailing address is 12212 TECHNOLOGY BLVD, AUSTIN TX, 78727. The medical instruments supplier can be reached via phone at 512-219-8020 or via email at [email protected]